We are live on ! Find out more
CNBT

Canandaigua National Bank & Trust Portfolio holdings

AUM $1.19B
This Fund
S&P 500
This Quarter Est. Return
-0.02%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$302M
AUM Growth
+$799K
Cap. Flow
+$2.71M
Cap. Flow %
0.9%
Top 10 Hldgs %
31.45%
Holding
194
New
9
Increased
75
Reduced
77
Closed
7

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$1.21M
2
GILD icon
Gilead Sciences
GILD
+$1.08M
3
DKS icon
Dick's Sporting Goods
DKS
+$1.05M
4
DE icon
Deere & Co
DE
+$718K
5
AWK icon
American Water Works
AWK
+$375K

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$721K
2
MCD icon
McDonald's
MCD
+$670K
3
RIG icon
Transocean
RIG
+$657K
4
BNY
Bank of New York Mellon
BNY
+$625K
5
AA icon
Alcoa
AA
+$489K

Sector Composition

Rank Sector Weight
1 Industrials 17.39%
2 Healthcare 13.4%
3 Technology 12.77%
4 Financials 12.51%
5 Energy 11.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XOM icon
1
ExxonMobil
XOM
$634B
$19.5M 6.45%
206,819
-4,706
-2% -$469K
FISI icon
2
Financial Institutions
FISI
$821M
$13.4M 4.45%
597,178
+540
+0.1% +$12.4K
SNA icon
3
Snap-on
SNA
$21.5B
$9.14M 3.03%
75,483
-100
-0.1% -$12.3K
GE icon
4
GE Aerospace
GE
$384B
$8.77M 2.91%
71,426
-412
-0.6% -$51.3K
VWO icon
5
Vanguard FTSE Emerging Markets ETF
VWO
$126B
$7.99M 2.65%
191,573
+1,060
+0.6% +$47.1K
JNJ icon
6
Johnson & Johnson
JNJ
$625B
$7.69M 2.55%
72,153
+686
+1% +$71.2K
RTX icon
7
RTX Corp
RTX
$301B
$7.59M 2.52%
114,213
-791
-0.7% -$54.2K
PG icon
8
Procter & Gamble
PG
$339B
$7.33M 2.43%
87,491
-1,946
-2% -$159K
AAPL icon
9
Apple
AAPL
$4.57T
$6.87M 2.28%
272,712
+9,492
+4% +$233K
JPM icon
10
JPMorgan Chase
JPM
$950B
$6.6M 2.19%
109,525
-7,079
-6% -$414K
IBM icon
11
IBM
IBM
$224B
$6.28M 2.08%
34,610
-302
-0.9% -$55K
ORCL icon
12
Oracle
ORCL
$423B
$5.11M 1.69%
133,464
-10,315
-7% -$418K
CVX icon
13
Chevron
CVX
$366B
$4.99M 1.65%
41,801
-100
-0.2% -$12.8K
VZ icon
14
Verizon
VZ
$196B
$4.71M 1.56%
94,135
+5,223
+6% +$260K
PAYX icon
15
Paychex
PAYX
$42.7B
$4.4M 1.46%
99,514
-4,778
-5% -$201K
PFE icon
16
Pfizer
PFE
$153B
$4.18M 1.39%
148,943
-1,694
-1% -$47.5K
MSFT icon
17
Microsoft
MSFT
$3.71T
$4.12M 1.37%
88,874
+790
+0.9% +$35.2K
T icon
18
AT&T
T
$163B
$4M 1.33%
150,412
+5,813
+4% +$155K
MCD icon
19
McDonald's
MCD
$195B
$3.9M 1.29%
41,140
-7,028
-15% -$670K
DIS icon
20
Walt Disney
DIS
$181B
$3.74M 1.24%
41,969
-1,015
-2% -$89.5K
MRK icon
21
Merck
MRK
$318B
$3.45M 1.14%
61,020
-1,357
-2% -$76.2K
KO icon
22
Coca-Cola
KO
$375B
$3.43M 1.14%
80,366
+590
+0.7% +$24.4K
PEP icon
23
PepsiCo
PEP
$190B
$3.35M 1.11%
36,031
-40
-0.1% -$3.65K
BMY icon
24
Bristol-Myers Squibb
BMY
$132B
$3.26M 1.08%
63,705
+1,173
+2% +$58.6K
HME
25
DELISTED
HOME PROPERTIES, INC
HME
$3.18M 1.06%
54,630
-1,825
-3% -$115K
1
2 3 4 5

Similar funds

CCS
Concentric Capital Strategies Stamford, Connecticut $1.19B AUM 44.7% 1-Year Est. Return
PAMJ
Parvus Asset Management Jersey St. Helier, Jersey $1.18B AUM 53.98% 1-Year Est. Return
EC
Elequin Capital New York $1.19B AUM 16.08% 1-Year Est. Return
MMFA
Main Management Fund Advisors San Francisco, California $1.19B AUM 26.23% 1-Year Est. Return
CTC
Chai Trust Company Chicago, Illinois $1.18B AUM 19.62% 1-Year Est. Return
SCM
Sone Capital Management New York $1.19B AUM 14% 1-Year Est. Return
NCMU
NAYA Capital Management (UK) London, United Kingdom $1.18B AUM 13.14% 1-Year Est. Return
OGC
Oak Grove Capital North Hampton, New Hampshire $1.18B AUM 84.79% 1-Year Est. Return

Canandaigua National Bank & Trust's Q3 2014 Portfolio in Review

As of Q3 2014, Canandaigua National Bank & Trust held 194 positions worth $302M, up 0.27% from $301M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Canandaigua National Bank & Trust's Q3 2014 filing shows 9 new, 75 increased, 77 reduced and 7 closed positions. Its largest new stake was Celgene Corp: 13,414 shares worth $1.27M. The largest sale was Teva Pharmaceuticals, an estimated $721K.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Technology.

  • Canandaigua National Bank & Trust's largest Q3 2014 buy was Celgene Corp: 13,414 shares worth $1.27M.
  • Canandaigua National Bank & Trust added most to Gilead Sciences in Q3 2014, an estimated $1.08M increase.
  • Canandaigua National Bank & Trust's biggest Q3 2014 reduction was Teva Pharmaceuticals, cutting an estimated $721K.
  • Canandaigua National Bank & Trust fully exited Transocean in Q3 2014, selling an estimated $657K.
  • Canandaigua National Bank & Trust's ten largest holdings make up 31% of its $302M portfolio in Q3 2014.
  • Canandaigua National Bank & Trust opened 9 new positions and closed 7 in Q3 2014.
  • Canandaigua National Bank & Trust's portfolio value rose 0.27% quarter-over-quarter to $302M.

Based on Canandaigua National Bank & Trust's 13F filing for Q3 2014, filed 13 Nov 2014.